EcoDrugPlus

Bcl2 Apoptosis Regulator

Ensembl ID : ENSPKIG00000002953
Gene Symbol: BCL2
3 Cross references
176 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSPKIG00000017884
Gene Symbol: BCL2L1
1 Cross references
287 Possible Orthologues:

Bcl2 Like 10

Ensembl ID : ENSPKIG00000021360
Gene Symbol: BCL2L10
1 Cross references
123 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSPKIG00000015504
Gene Symbol: BCR
3 Cross references
205 Possible Orthologues:

Bdnf/nt-3 Growth Factors Receptor-Like

Ensembl ID : ENSPKIG00000010169
Gene Symbol: LOC111851431
3 Cross references
210 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSPKIG00000013740
Gene Symbol: BTK
3 Cross references
204 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSPKIG00000021084
Gene Symbol: BTK
4 Cross references
137 Possible Orthologues:

C-C Chemokine Receptor Type 9-Like

Ensembl ID : ENSPKIG00000003909
Gene Symbol: LOC111834064
3 Cross references
188 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSPKIG00000009754
Gene Symbol: CCR9
3 Cross references
193 Possible Orthologues:

C-X-C Chemokine Receptor Type 4-Like

Ensembl ID : ENSPKIG00000010723
Gene Symbol: LOC111858385
3 Cross references
133 Possible Orthologues:

C-X-C Motif Chemokine Receptor 1

Ensembl ID : ENSPKIG00000019026
Gene Symbol: CXCR1
3 Cross references
275 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSPKIG00000025601
Gene Symbol: CXCR4
4 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).